Fosun Antigen (Chengdu) Biopharmaceutical

Fosun Antigen (Chengdu) Biopharmaceutical is a China-based biotechnology company specializing in the research, development, and manufacturing of innovative vaccines. As a subsidiary of Fosun Pharma, the company focuses on bacterial conjugate vaccines, most notably its 13-valent pneumococcal conjugate vaccine (PCV13) which is currently in late-stage clinical development. The company operates a large-scale manufacturing facility in the Chengdu Tianfu International Bio-town designed to meet international GMP standards. Its pipeline also includes a next-generation 24-valent pneumococcal vaccine and other multivalent conjugate candidates targeting infectious diseases. Fosun Antigen aims to address significant unmet needs in global public health by providing high-quality, affordable vaccine solutions for pediatric and adult populations.